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Time-resolved emission spectra (TRES) have been used to detect conformational changes of intrinsic 
tyrosines within bovine insulin at a physiological pH. The approach offers the ability to detect the 
initial stages of insulin aggregation at the molecular level. The data analysis has revealed the 
existence of at least three fluorescent species undergoing dielectric relaxation and significant spectral 
changes due to insulin aggregation. The results indicate suitability of the intrinsic TRES approach for 
insulin studies and for monitoring its stability during storage and aggregation in insulin delivery 
devices.  
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Protein aggregation has attracted significant interest due to its role in neurodegenerative diseases  
including $O]KHLPHU¶V GLVHDVH $', 3DUNLQVRQ¶V GLVHDVH (PD) and diabetes type II.1,2 Proteins and 
their proteolytic products can undergo conformational changes allowing them to self-assemble into 
nanostructured amyloid fibrils. Such structures then accumulate into microscopic deposits, senile 
plaques, which are found in the post-mortem brains of AD patients. However, correlations between 
the amyloid fibrils and the extent of cognitive loss have yet to be reported. By contrast, cytotoxicity is 
attributed to the soluble, prefibrillar forms of amyloid,3 whereas reducing fibril formation does not 
necessarily lower cytotoxicity.4 Taken together these factors suggest that insoluble amyloid fibrils are 
the repositories of soluble intermediates that remain in equilibrium with insoluble fibrillar forms.5 
Therefore, it is believed that the fibril-type of protein aggregation should follow three main steps: 1)  
misfolding of the monomeric form into a low oligomer, which 2) nucleates the formation of elongated 
proto-fibrils that 3) aggregate forming  mature fibrils.6,7 Most importantly, proteopathies ± 
neurodegenerative disorders caused by protein misfolding and aggregation ± are caused by different 
proteins,6 but all result from the same generic mechanism of fibrillogenesis. Yet, a capability to 
monitor this very process of persistent protein aggregation is lacking. 
One protein that is prone to fibrillation is insulin - a hormone which regulates blood glucose levels 
within the body. Patients with diabetes do not produce enough insulin to stabilize blood glucose levels 
and thus need additional injections of this hormone. Insulin is an extensively studied protein because 
of complications caused by its aggregation. For example at frequent injection sites long fibrous insulin 
structures have been found.8±10 Also, the long term storage of insulin has been shown to lead to 
aggregation, thus impacting the efficacy and cost of diabetes treatment.11 Specifically, the 
transportation and storage at higher temperatures increases the likelihood of instability since fibril and 
covalent polymer formation are temperature-dependent. The devices used in insulin infusion therapy 
are particularly susceptible because wearing at body heat, shaking of the reservoir with bubble 
formation and interaction with hydrophobic surfaces of the infusion cannula all encourage monomer 
formation and partial monomer unfolding, the prerequisites for fibril formation. Moreover, serum 
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samples taken from patients suffering from PD displayed an autoimmune response to insulin fibrils, 
which may suggest that insulin aggregation may play a role in neurodegenerative disease.12   
Insulin13 consists of 51 residues with two polypeptide chains, A and B. Chain A has 21 amino acid 
residues and a disulphide bridge between two cysteine amino acids while chain B is composed of 30 
amino acids. Both chains are covalently linked together by two cysteine bridges. There are seven 
intrinsic fluorophores in an insulin particle: two tyrosine (Tyr) residues on chain A and two Tyr and 
three phenylalanine (Phe) residues on chain B. Insulin is predominantly stored as a hexamer stabilized 
by zinc ions and favours hexamer conformations at pH 7.4.  
Several techniques have been employed to study fibril formation including circular dichroism 
(CD),14,15 transmission electron microscopy (TEM),16 atomic force microscopy (AFM),17 X-ray 
diffraction18 and others.19±21  
CD spectroscopy studies showed that insulin adopts Į-helical conformations that can convert to 
appreciably ȕ-pleated structures as a function of time. X-ray diffraction studies showed structural 
similarities between insulin fibrils and other proteins associated with amyloid formation, in which 
individual ȕ-strands run perpendicular to the main fibril axis. The cross-ȕ ILEULO VWUXFWXUH is the 
hallmark of amyloid fibrils.   
Fluorescence spectroscopy is one of the most informative techniques to study protein folding, self-
assembly and to monitor conformational changes. It offers an excellent combination of speed, ease of 
use and nanometre-level molecular information.22 Fluorescence benefits from labelling the protein 
assembly of interest with extrinsic fluorophores such as Thioflavin T (ThT), Auramine O, ANS and 
Congo red13,23±25 to probe secondary structure alterations as a function of fluorescence responses. The 
use of these dyes has given a deeper understanding of protein fibrillation. The approaches used 
include conventional fluorescence spectra,26 fluorescence decay,27 and fluorescence correlation 
spectroscopy.28 One of main findings observed in ThT-based experiments was ThT fluorescence 
intensity showing a sigmoidal function with negligible fluorescence intensity observed in the early 
stages, gradual increase over time and a plateau in the final stage. As ThT quantum yield increases 
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from nearly 0 to a higher value on binding to the E-sheets of probed fibrils, this result indicates that 
fibril formation by insulin undergoes three stages: an initial lag phase, growth phase and final 
equilibrium phase.   
However, the use of extrinsic fluorophores is associated with some limitations as they can perturb 
protein kinetics, which leads to ambiguities in interpretation, lacks the sensitivity required for 
studying prefibrillar structures29 and different probes used on the same system can yield different 
signals30. In this study we attempt to overcome these limitations with the use of intrinsic fluorophores 
to detect conformational changes during insulin fibrillation. Our premise is that since insulin has four 
tyrosine residues which are sensitive to the local microenvironments, their fluorescence response may 
carry information relevant to the insulin aggregation and fibrillation.  In previous studies of tyrosine 
response to insulin fibrillation, e.g.13, its fluorescence was monitored at the fixed wavelength only and 
insulin fibril formation was accelerated by elevating temperatures and/or decrease pH of the aqueous 
solution, which is  inconsistent with physiological conditions.   
In this paper we report insulin¶V tyrosine fluorescence intensity decay and time-resolved emission 
spectra (TRES) to extract in-depth information on insulin aggregation kinetics under physiological pH 
conditions. Using time-resolved techniques carries significant advantages over the time-integrated 
approaches22, the latter offering limited information on the dynamics of molecules in the excited-
states. 
Bovine insulin and phosphate-buffered saline pH 7.4 (PBS) were purchased from Sigma-Aldrich and 
was used without further purification. ȝ0solution of bovine insulin was prepared in PBS buffer 
(0.01 M) and sonicated until completely dissolved. The sample was kept and measured at 22 ?C. The 
steady state absorption and fluorescence spectra measurements were recorded using the Lambda 25 
UV-Vis spectrometer (Perkin-Elmer) and Fluorolog (Horiba Scientific), respectively. For TRES 
measurements, the fluorescence decays were recorded on a DeltaFlex fluorescence lifetime system 
(Horiba Jobin Yvon IBH Ltd, Glasgow) using time correlated single photon counting (TCSPC). A 
NanoLED producing ~600 ps pulses at 279 nm31 was used to excite the intrinsic tyrosine fluorescence 
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at detection wavelengths O ranging from 290-350 nm at 5 nm intervals. To avoid the influence of 
rotational effects on fluorescence decays, a vertically oriented polariser in the excitation channel and a 
polarizer at the magic angle (54.7 ?) in the detection channel were added in the optical path. 
Fluorescence decays recorded at the series of O values were fitted to a multi-exponential model 
function:  
ࡵࣅሺ࢚ሻ ൌ  ෍ ࢻ࢏ሺࣅሻ ܍ܠܘ ൬ െ࢚࣎࢏ሺࣅሻ൰ࡺ࢏ୀ૚ ሺ૚ሻ 
where ߙ௜ሺOሻ is the i-th pre-exponential component and ߬௜ሺOሻ is the relevant fluorescence lifetime. The 
fitting procedure applied here assumed that the experimental decay curve is the combination of the 
fluorescence decay function (1), the background signal and the contribution of the scattered excitation 
light as described previously.32 The nonlinear least squares approach using Ȥ2 and weighted residuals 
as the goodness of fit criteria has shown that a 3-exponential model (N=3) is sufficient to provide an 
accurate representation of the fluorescence decays. The recovered parameters ߙ௜ሺߣሻ and ߬௜ሺߣሻ were 
then used to create TRES.  The time resolved emission spectra ܫ௧ሺߣሻ were obtained according to:33,34  
ࡵ࢚ሺࣅሻ ൌ  ෍ ࢻ࢏ ሺࣅሻ܍ܠܘ ൬ െ࢚࣎࢏ሺࣅሻ൰ ࡿሺࣅሻ ? ࢻ࢏ሺࣅሻ࣎࢏࢏૜࢏ୀ૚ ሺ૛ሻ 
where ܵሺߣሻis the steady-state spectrum of the sample. Eachܵሺߣሻspectrum has been corrected for a 
dark signal offset, fluctuations in the lamp output and the wavelength response of the 
monochromator¶Vdiffraction grating. In order to obtain TRES as function of wavenumber the ܫ௧ሺߣሻ 
were converted to ܫ௧ሺߥሻ by:35,36 
ࡵ࢚ሺࣇሻ ൌ  ࣅ૛ࡵ࢚ሺࣅሻ                   (3) 
In the next stage the model of TRES ݃௧ሺߥሻ, based on the Toptygin-type approach37 where the multiple 
normalised Gaussian distributions were used to represent the spectral shapes of fluorescent 
components 
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ࢍ࢚ሺࣇሻ ൌ  ૅ૜ ෍ ࡭࢏ሺ࢚ሻඥ૛࣊࣌࢏ሺ࢚ሻ૛ ࢋ࢞࢖൭ି൫ࣇିࣇ࢏ሺ࢚ሻ൯૛૛࣌࢏ሺ࢚ሻ૛ ൱૜࢏ ሺ૝ሻ 
was fitted to the experimental spectra (3). Here ܣ௜ሺݐሻ is the contribution of each component, ߥ௜ሺሻ is 
the peak position, and ߪ௜ሺሻ is the half-width of the distribution. In practice a sum of 3 Gaussian 
distributions was fitted to the expression Q-3ܫ௧ሺߥሻ.  
Fluorescence spectra of insulin at different times of aggregation are shown in Figure 1. The results 
cover the period from about 20 minutes after sample preparation up to over 600 hours.  The intensity 
of the initial peak at about 300 nm gradually decreases and the spectrum becomes broader and shifts 
towards longer wavelengths. Normalised spectra (Figure 1B) show at least three characteristic peak 
values about 300 nm, 315 nm and 340 nm, indicating fluorescence from the products of the complex 
conformational changes, which cannot be explained on the basis of the steady-state studies only. The 
drop in Tyr fluorescence intensity is consistent with the result reported by Bekard and Dunstan,13 
except that in the conditions of their experiment, pH 1.9 and temperature 60qC, the aggregation 
occurred within 10 hours, while in our experiment, pH 7.4 and 22qC, it takes about 30 days. This 
result confirms that at physiological pH and in the presence of Zinc ions the insulin hexamer 
formation is stable, which is exploited for stabilisation of insulin in neutral pH drug product 
formulations.  
The fluorescence intensity decays of insulin sample were recorded at different wavelengths and at 
different points of aggregation. Figure S1 in Supplementary Material (SM) demonstrates strong 
lifetime-wavelength dependence where the fluorescence intensity decays measured at the short 
wavelength side of the spectrum (290 nm) decay more rapidly than the decays measured on the longer 
wavelength side (350 nm). This is consistent with the lifetime-wavelength correlation observed in 
proteins38,39. The effect may be explained by the fluorescence intensity decay measured at the short-
wavelength side of the spectrum being accelerated by the peak of the transient emission spectrum 
shifting away from the detection wavelength due to dielectric relaxation, thus causing further decrease 
in intensity. For the same reason the decay detected at the long-wavelength side of the spectrum 
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decreases at slower rate, as the peak of the shifting transient emission spectrum moves towards the 
detection wavelength. However, the detailed analysis of the recovered fluorescence lifetimes Wi(O) 
(see Table S1 and Figure S1C  in SM) shows that although the non-significant increase in two shorter 
lifetimes Wi(O)  is typical for the lifetime-wavelength dependence, the strong increase in the longest 
lifetime has to be a consequence of significant structural change. The comparison of Figure S1A and 
Figure S1B and the differences in the Wi(O) on Figure S1C show that the lifetime components of 
insulin after 690 hours of aggregation have increased as compared to the lifetimes observed at 0.35 
hours (21 min). This is likely to be due to numerous effects related to the complexity of insulin 
photophysics. Indeed, insulin has four tyrosine residues and three of them are buried in the protein40 
and therefore can be simultaneously involved in both hydrophobic and hydrophilic interactions. 
Therefore, the alterations in the local environments of the tyrosines at different stages of insulin 
aggregation are likely to result in more complex fluorescence kinetics. Nevertheless, because the 
fluorescence lifetime components Wi(O) are dependent of O, the decay associated spectra (DAS) 
technique, assuming the spectrum to be the sum of the stationary spectra of few different forms, is not 
applicable and the TRES approach in needed. 
TRES ܫ࢚ሺߥሻ were determined for the insulin sample at different times after its preparation.  The 
examples of the Q-3ܫ࢚ሺߥሻ plots vs. time for the fresh (0.35 hours after preparation) sample and the old 
(690 hours after preparation) sample are shown on Figure 2A and Figure 2B, respectively. Both sets 
of plots Q-3ܫ࢚ሺߥሻ display peaks around 33000 cm-1 which intensities gradually decrease with time after 
excitation. The main difference between both samples is the emergence of a broader structure at 
shorter wavenumbers observed in the old sample. This is better demonstrated in the normalised plots 
of Figure 2C and Figure 2D where it appears at ~30,000 cm-1.  
To obtain fuller and quantitative information on the observed spectral changes, all Q-3ܫ࢚ሺߥሻ spectra 
were modelled by the sum of 3 normalised Gaussian profiles (the sum of two Gaussians fitted poorly 
to the experimental data, while the F2 values obtained for the triple-Gaussian fitting were in the 
acceptable range 1.00 y 1.19. Figure S2 (SM) shows the examples of fitting the triple-Gaussian 
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function to the data obtained for the fresh and old samples (as in the Figure 2) for the times 0.25 ns 
and 10 ns after excitation. The fresh sample shows initially (at 0.25 ns after excitation) two emitting 
species with the maxima around 34000 and 33000 cm-1 (as recovered from Gaussian fitting) and, after 
10 ns, the additional component with the peak at 30000 cm-1. In the old sample the initial spectrum 
shows three peaks: at 34000 and 33000 cm-1 as in the fresh sample, and the dominating component 
with the peak at 31000 cm-1. After 10 ns this peak shifts to around 29500 cm-1.  
The above observations seem to be consistent with compilation of two processes characteristic for 
proteins21: excitation-triggered conformational change of insulin molecules on a nanosecond time 
scale and their aggregation in the time-scale of several hours to days. 
 As can be seen in Figure 2D there is no gradual shift of the spectrum on the nanosecond scale, which 
would be consistent with the dielectric relaxation, but the spectrum is rather a sum of two profiles 
with the maxima at 33000 cm-1 and 30000 cm-1, which suggests that the 30000 cm-1 profile is the 
conformational form. On the other hand, the origin of the profile with the peak at 31000 cm-1 in the 
initial spectrum of the old sample (Figure S2C) can be explained as the result of aggregation of the 
molecules that emitted at 33000 cm-1 before their aggregation. This also explains the reduced intensity 
of the 33000 cm-1 band. The aggregates also seem to undergo a conformational change in a ns time 
scale, which causes further shift of their spectra maximum to about 29500 cm-1 as is seen in the old 
sample TRES at 10 ns (Figure S2D).
The peaks of the Gaussian profiles fitted to the experimental Q-3ܫ࢚ሺߥሻ curves are plotted in Figure 3A. 
The locations of peaks emitting around 34000 cm-1 and 33000 cm-1 seem to be weakly dependent on 
the age of the sample and show a non-significant spectral shift towards longer wavelengths which is 
consistent with the effect of dielectric relaxation. Indeed, contrary to the most of fluorophores for 
which dielectric relaxation is much faster than fluorescence decay, the dielectric relaxation of intrinsic 
fluorophores like tyrosine and tryptophan in proteins usually occurs on the same nanosecond time 
scale as fluorescence which leads to more complex photophysics. 
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The spectral shifts of the third component, however, are unlikely to be due the dielectric relaxation 
because their values are significant, some emission about 33000 cm-1 remains in the spectrum at later 
times and the shift of the peak vs. time dependence does not always have a dielectric relaxation 
exponential character, but sigmoidal shape in some cases. Therefore, we currently interpret the 
spectral shifts of the third component as a result of the excitation-triggered conformational changes of 
the insulin aggregates. The variations in the third peak position vs. time plots observed at different 
ages of the sample may be explained by different compositions of the insulin aggregates during its 
aging.  
Since our model of the insulin fluorescence spectra (eqtn (4)) uses the normalised Gaussian 
distribution functions, the amplitudes Ai(t) represent the contributions of fluorescence from three 
components. Consequently, the time decays of Ai(t) can be regarded as the fluorescence decay of these 
components. Figure 3B shows the Ai(t) decays observed in the oldest sample. Exponential fitting of 
these curves gives the fluorescence lifetimes of the 34000 cm-1 and 33000 cm-1 forms as 0.96 ns and 
1.10 ns, respectively, while the fluorescence lifetime of the conformational form is longer ± 1.39 ns. 
Note that these values are substantially shorter than the longest lifetime components recovered from 
the raw decays (Figure S1C and Table S1 in SM), which shows how effects like dielectric relaxation 
and conformational change in the fluorophore may complicate interpretation of the lifetime data. 
By using the TRES technique we have provided a new insight into the tyrosine fluorescence kinetics 
of bovine insulin during its aggregation. We have observed the fluorescence of two forms showing 
peak emission at 34000 cm-1 and 33000 cm-1 and the fluorescence of the product of conformational 
change of the 33000 cm-1 form with the peak emission at 30000 cm-1. As the insulin solution ages, the 
aggregation of the 33000 cm-1 form occurs resulting in the shift of the initial aggregate emission peak 
to 31000 cm-1.  The aggregates also undergo conformational change after excitation leading to the 
emission with the peak shifted to ~29000 cm-1.  Identification and further characterisation of the 
fluorescent insulin forms will require further TRES studies for the samples at different concentrations, 
temperatures and pH conditions.  Nevertheless, we have demonstrated that tracking the changes in the 
intrinsic fluorescence offers a sensitive way of studying unfolding and aggregation of insulin when 
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not modified by extrinsic markers and in the undisturbed clinically relevant environment, for example 
inside a plastic delivery cannula or within a storage vial. 
Supplementary Material (SM) ± presents the fluorescence intensity decays of the fresh and older 
insulin samples (detected at different emission wavelengths) and the changes in the recovered 
lifetimes (Fig. S1), examples of fitting the model of TRES (eqtn.4) to the actual spectra (Fig. S2) and 
the results of fitting the fluorescence intensity decays IO(t) of insulin sample recorded at different 
wavelengths and at different points of aggregation (Table S1).   
The authors thank Prof. John Pickup (*X\¶V +RVSLWDO /RQGRQ IRU KLV YDOXDEOH GLVFXVVLRQ RQ the 
importance of insulin stability. 7KHZRUNZDVVXSSRUWHGLQSDUWE\WKH8.¶V'HSDUWPHQWIRU%XVLQHVV
Energy and Industrial Strategy.  
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Figures captions: 
 
Figure 1)OXRUHVFHQFHVSHFWUDRIȝ0LQVXOLQLQ3%6EXIIHUDWVHOHFWHGWLPHV
and 621 hours after sample preparation A) and the normalised spectra B). 
 
Figure 2: TRES spectra for A) 0.35 and B) 690 hours old insulin sample determined at 0, 0.25, 0.5, 
0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, and 10 ns after excitation. Plots C) and D) show the same spectra 
after normalisation. 
 
Figure 3: A) Time evolution of the peak positions of the fluorophores emitting at 34000 cm-1 (dotted 
line), 33000 cm-1 (dashed line), and 30000 cm-1 (solid line) after excitation for the sample measured 
after 0.35 (), 22 (z), 68 (S), 93 () and 690 (ۻ) hours of aggregation. Plot B) shows time evolution 
of the contributions of Gaussian components Ai(t) in the oldest sample. Shown are the forms with the 
initial peak at 34000 cm-1 (S), 33000 cm-1 (z), and 30000 cm-1 (). 
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Figure S1: Fluorescence intensity decays for detection wavelengths of 290, 320, and 350 nm, for A) 
0.35 hours  and B) 690 hours after insulin sample preparation. The instrumental pulse profile is 
denoted as Prompt. Plot C) shows changes in three lifetimes obtained from fitting the fluorescence 
intensity decays of the 0.35 hours old (z) and 690 hours old (S) insulin sample.  
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Table S1: The results of fitting the fluorescence intensity decays IO(t) of insulin sample 
recorded at different wavelengths O and at different points of aggregation T. 
 
T=0.35 hours 
Wavelength 
(nm) 
B1 ʏ ? ?ŶƐ ? B2 ʏ ? ?ŶƐ ? B3 ʏ ? ?ŶƐ ? F2 
290 о0.05340 0.43 0.05000 0.50 0.00936 1.33 1.22 
295 0.48466 1.15 -1.18700 1.20 0.73150 1.24 1.09 
300 0.03364 1.02 0.02579 2.31 -0.02030 2.40 0.92 
305 0.03638 0.99 0.02204 2.16 -0.01430 2.30 1.06 
310 0.02771 0.13 0.03398 0.97 0.01183 1.75 1.06 
315 0.00940 0.27 0.03557 1.06 0.00702 1.98 1.05 
320 0.01753 0.28 0.03685 1.15 0.00390 2.36 1.14 
325 0.016283 0.31 0.03634 1.21 0.00238 2.89 1.16 
330 0.01617 0.38 0.03544 1.26 0.00184 3.46 1.17 
335 0.01853 0.37 0.03493 1.28 0.00176 3.95 1.18 
340 0.01870 0.40 0.03206 1.34 0.00178 4.39 1.19 
345 0.01740 0.55 0.03000 1.42 0.00194 4.79 1.19 
350 0.01990 0.57 0.02550 1.51 0.00212 5.15 1.19 
 
T=22 hours 
Wavelength 
(nm) 
B1 ʏ ? ?ŶƐ ? B2 ʏ ? ?ŶƐ ? B3 ʏ ? ?ŶƐ ? F2 
290 0.02107 0.92 0.00666 1.78 -0.00046 3.52 1.16 
295 0.03352 0.94 0.08005 2.35 -0.07298 2.40 1.13 
300 0.03518 0.90 0.03338 2.17 -0.02379 2.33 1.14 
305 0.02524 0.73 0.02231 1.46 -0.00001 >350
* 
1.18 
310 0.02641 0.71 0.02304 1.47 -0.00001 >350
* 
1.27 
315 0.03479 0.87 0.15514 2.07 -0.14299 2.10 1.12 
320 0.01773 0.23 0.02875 0.90 0.01551 1.64 1.06 
325 0.02049 0.27 0.03560 1.07 0.00593 2.10 1.18 
330 0.02107 0.33 0.03428 1.15 0.00367 2.50 1.27 
335 0.01870 0.43 0.03255 1.25 0.00194 3.39 1.18 
340 0.02373 0.39 0.03165 1.27 0.00199 3.75 1.14 
345 0.02232 0.43 0.02970 1.33 0.00189 4.32 1.23 
350 0.02293 0.44 0.02815 1.35 0.00231 4.47 1.26 
*
The lifetime >350 ns (350 ns is the high-limit value of the lifetime considered by the software) and a 
very low and negative value of the associated pre-exponential factor indicate that the third 
component contributes to the background signal and the fluorescence decay is 2-exponential.   
 
 
T=68 hours 
Wavelength 
(nm) 
B1 ʏ ? ?ŶƐ ? B2 ʏ ? ?ŶƐ ? B3 ʏ ? ?ŶƐ ? F2 
290 0.02360 0.89 0.00974 1.58 -0.00008 6.43 1.18 
295 0.03760 0.92 0.05190 2.37 -0.04450 2.46 1.05 
300 0.03232 0.85 0.01121 1.61 о0.00001 >350* 1.20 
305 0.03007 0.71 0.02145 1.50 о0.00001 >350* 1.07 
310 0.02520 0.73 0.02230 1.46 о0.00001 >350* 1.18 
315 0.01570 0.52 0.03200 1.17 0.00320 2.41 1.17 
320 0.01760 0.50 0.03210 1.23 0.00185 3.15 1.19 
325 0.02130 0.51 0.03036 1.31 0.00125 4.12 1.05 
330 0.02311 0.58 0.02668 1.38 0.00135 4.64 1.08 
335 0.02260 0.52 0.02807 1.37 0.00176 4.90 1.08 
340 0.02982 0.80 0.01577 1.68 0.00188 5.41 1.13 
345 0.02599 0.58 0.02323 1.55 0.00231 5.66 1.13 
350 0.02680 0.61 0.02117 1.63 0.00287 5.79 1.16 
 
T=93 hours 
Wavelength 
(nm) 
B1 ʏ ?(ns) B2 ʏ ? ?ŶƐ ? B3 ʏ ? ?ŶƐ ? F2 
290 0.02620 0.93 0.00574 1.80 -0.00010 6.34 1.06 
295 0.03180 0.83 0.01311 1.59 -0.00001 57.03 1.18 
300 0.02150 0.22 0.03250 0.92 0.01251 1.65 1.02 
305 0.01600 0.44 0.03480 1.14 0.00278 2.44 1.05 
310 0.01870 0.39 0.03570 1.17 0.00206 3.04 1.17 
315 0.02360 0.58 0.02820 1.33 0.00116 4.25 1.01 
320 0.02190 0.46 0.03180 1.28 0.00173 4.44 1.15 
325 0.02333 0.53 0.02821 1.36 0.00190 4.98 1.15 
330 0.02447 0.56 0.02585 1.43 0.00242 5.24 1.17 
335 0.02563 0.56 0.02433 1.51 0.00287 5.53 1.16 
340 0.02818 0.62 0.01979 1.69 0.00326 5.80 1.05 
345 0.02654 0.66 0.01840 1.82 0.00376 6.03 1.09 
350 0.02700 0.77 0.01490 2.10 0.00415 6.23 1.18 
 
 
 
 
 
 
T=690 hours 
Wavelength 
(nm) 
B1 ʏ ? ?ŶƐ ? B2 ʏ ? ?ŶƐ ? B3 ʏ ? ?ŶƐ ? F2 
290 0.33000 0.03 0.00709 0.86 0.00379 1.71 1.30 
295 0.14342 0.05 0.01948 1.03 0.00296 2.49 1.11 
300 0.01700 0.61 0.02040 1.35 0.00173 3.81 1.09 
305 0.02350 0.67 0.02010 1.54 0.00179 4.75 0.99 
310 0.02470 0.67 0.01990 1.64 0.00235 5.21 1.13 
315 0.02980 0.81 0.01450 2.01 0.00272 5.80 1.14 
320 0.02780 0.85 0.01420 2.24 0.00312 6.28 1.07 
325 0.02549 0.71 0.01827 2.07 0.00452 6.17 1.08 
330 0.02517 0.76 0.01716 2.32 0.00491 6.48 1.05 
335 0.02142 0.76 0.01798 2.34 0.00572 6.53 1.07 
340 0.02070 0.65 0.01893 2.27 0.00701 6.36 1.19 
345 0.02008 0.71 0.01822 2.43 0.00712 6.58 1.08 
350 0.02063 0.66 0.01789 2.47 0.00754 6.58 1.08 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Figure S2: Experimental TRES data () fitted to a 3 Gaussian model for the sample measured at 0.35 
(A,B) and 690 (C,D) hours after preparation. The left (A,C) and right (B,D) panels are TRES 
determined at 0.25 ns and 10 ns after excitation, respectively. The Gaussian curves  labelled 1, 2, and 
3 represent the individual fluorophores emitting at 34000 cm-1, 33000 cm-1, and 30000 cm-1 
respectively.  
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